Comparing the Effectiveness of Oral Versus Intravenous Pain Medicine for Suction Curettage (D&C) - Full Text View

Purpose

The main objective of this study is to determine the equivalency of oral conscious sedation and intravenous conscious sedation for first trimester surgical abortion. We hypothesize that oral conscious sedation will be equivalent to intravenous conscious sedation for pain control. Additional objectives include describing subject satisfaction with each method of pain control and characteristics of each method such as side effect profile, recovery room time, and postoperative pain.

Condition	Intervention
Undesired Pregnancy	Drug: oxycodone + lorazepam versus fentanyl + midazolam

MedlinePlus related topics:

Abortion Pregnancy Loss

ChemIDplus related topics:

Fentanyl Citrate Fentanyl Oxycodone Oxycodone hydrochloride Midazolam Midazolam hydrochloride Midazolam maleate Lorazepam

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study

Official Title:	A Randomized Clinical Trial Comparing Oral Conscious Sedation With Intravenous Conscious Sedation for First Trimester Surgical Abortion

Further study details as provided by Planned Parenthood League of Massachusetts:

Primary Outcome Measures:

Pain scale

Secondary Outcome Measures:

Measures of satisfaction, side effects, recovery time

Enrollment:	132
Study Start Date:	June 2006
Study Completion Date:	July 2007
Primary Completion Date:	July 2007 (Final data collection date for primary outcome measure)

Detailed Description:

The main objective of this study is to determine the equivalency of oral conscious sedation (oxycodone 10mg PO plus lorazepam 1mg SL) and intravenous conscious sedation (fentanyl 100 µg plus midazolam 2mg) for first trimester surgical abortion. We hypothesize that oral conscious sedation will be equivalent to intravenous conscious sedation as defined by ± 1 point on a 21-point pain scale. Subsidiary objectives include describing subject satisfaction with each method of pain control and characteristics of each method such as side effect profile, recovery room time, and postoperative pain.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Age 18 or older.
Undesired pregnancy between 6 0/7-12 6/7 weeks gestation.
Has already signed consent for pregnancy termination.
Eligible for IV sedation per clinic protocol.

Exclusion Criteria:

Under 120 lbs.
Allergies to any of the drugs being studied.
Chronic narcotics, barbiturates or benzodiazepine use within the past year.
History of IV drug use within the last year.
Inability to give informed consent.
Does not speak English or Spanish and does not have translator for all study procedures
Previously participated in study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00337792

Locations


United States, Massachusetts
	Planned Parenthood League of Massachusetts
	Boston, Massachusetts, United States, 02215

Sponsors and Collaborators

Planned Parenthood League of Massachusetts

An anonymous Foundation.

Investigators


Principal Investigator:	Alisa B Goldberg, MD, MPH	Brigham and Women's Hospital and Planned Parenthood League of Massachusetts

More Information

Responsible Party:	Planned Parenthood League of MA ( Alisa B. Goldberg, MD, MPH/Director of Clinical Research and Training )
Study ID Numbers:	2005-P-002284/1
First Received:	June 15, 2006
Last Updated:	December 20, 2007
ClinicalTrials.gov Identifier:	NCT00337792
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lorazepam

Fentanyl

Oxycodone

Pain

Abortion, Spontaneous

Midazolam

ClinicalTrials.gov processed this record on October 15, 2008

Sponsors and Collaborators:	Planned Parenthood League of Massachusetts An anonymous Foundation.
Information provided by:	Planned Parenthood League of Massachusetts
ClinicalTrials.gov Identifier:	NCT00337792